Lucid Diagnostics INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
SCHEDULE 13G/A: Investment Funds Disclose 2.0% Stake in Lucid Diagnostics Inc.
Ayrton Capital LLC, Alto Opportunity Master Fund, SPC, and Waqas Khatri have jointly disclosed a 2.0% beneficial ownership stake in Lucid Diagnostics Inc. as of December 31, 2024.